Cargando…
First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement
Histone deacetylases (HDACs) are important epigenetic regulators involved in many diseases, especially cancer. Five HDAC inhibitors have been approved for anticancer therapy and many are in clinical trials. Among the 11 zinc‐dependent HDACs, HDAC10 has received relatively little attention by drug di...
Autores principales: | Herp, Daniel, Ridinger, Johannes, Robaa, Dina, Shinsky, Stephen A., Schmidtkunz, Karin, Yesiloglu, Talha Z., Bayer, Theresa, Steimbach, Raphael R., Herbst‐Gervasoni, Corey J., Merz, Annika, Romier, Christophe, Sehr, Peter, Gunkel, Nikolas, Miller, Aubry K., Christianson, David W., Oehme, Ina, Sippl, Wolfgang, Jung, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308754/ https://www.ncbi.nlm.nih.gov/pubmed/35608330 http://dx.doi.org/10.1002/cbic.202200180 |
Ejemplares similares
-
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors
por: Morgen, Michael, et al.
Publicado: (2020) -
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
por: Darwish, Salma, et al.
Publicado: (2022) -
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
por: Kolbinger, Fiona R., et al.
Publicado: (2018) -
Development
of First-in-Class Dual Sirt2/HDAC6 Inhibitors
as Molecular Tools for Dual Inhibition of Tubulin Deacetylation
por: Sinatra, Laura, et al.
Publicado: (2023) -
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
por: Simoben, Conrad V., et al.
Publicado: (2018)